NeoLight
NeoLight is a Scottsdale-based medical device company developing neonatal care technologies including phototherapy (Skylife), retinal imaging (Phoenix ICON), brain monitoring (néo CFM), and transport devices, serving hospitals, NICUs, and home healthcare markets across 95+ countries.
- Company typePrivate
- Founded2014
- HeadquartersScottsdale, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What NeoLight does
NeoLight is a Scottsdale, Arizona-based medical device company founded in 2014 that develops a portfolio of neonatal care technologies organized across five product categories: ocular screening (Phoenix ICON, Phoenix ICON GO, and Phoenix CONNECT telemedicine platform), jaundice treatment (Skylife phototherapy system), brain monitoring (néo CFM with aEEG), non-nutritive sucking therapy (P.A.L. Pacifier Activated Lullaby), and neonatal transport/thermoregulation (NEOPOD, BABYPOD series, SCANPOD, BP37). Core technologies include patented Direct Illumination retinal imaging, Skylife's 3D Light Array providing 40% body surface coverage, and the Phoenix CONNECT cloud-based telemedicine platform that connects nursing, ophthalmology, and neonatology teams for remote expert screening.
The company serves hospitals, NICUs, ophthalmology departments, and home healthcare settings, with claimed reach into 90% of America's top children's hospitals and distribution in more than 95 countries. Its go-to-market combines direct enterprise sales in the US and Canada with GPO contracts (Vizient, Capstone Health Alliance, Premier KIINDO) for hospital network access and international distribution partners for global markets. Revenue is generated through capital medical device hardware sales, with the Phoenix CONNECT platform providing potential recurring software revenue. Strategic acquisitions have been central to portfolio expansion, including Phoenix Technology Group (Nov 2021) for ophthalmic imaging and P.A.L. musical pacifier technology (Oct 2022), with an announced agreement to acquire InterVIEW Medical Systems (April 2023).
NeoLight has raised approximately $18.4 million across eight funding rounds from 2015-2022, with the largest disclosed round being $7 million in August 2020 from Dignity Health, Honor Health, and the Roethlisberger family. The company holds multiple FDA 510(k) clearances and issued US patents, and is led by co-founder and CEO Vivek Kopparthi alongside a management team including CCO MaryBeth Smith, CFO Ronald Wysochansky, and co-founder Deepak Krishnaraju, with a board that includes former Stryker executive Jim Heath and other medical device veterans.
NeoLight firmographics
Firmographics- Name
- NeoLight
- Legal name
- NeoLight LLC
- Website
- https://theneolight.com
- Company type
- Private
- Founded year
- 2014
- Headcount range
- 11–50 employees
- Short description
- NeoLight is a Scottsdale-based medical device company developing neonatal care technologies including phototherapy (Skylife), retinal imaging (Phoenix ICON), brain monitoring (néo CFM), and transport devices, serving hospitals, NICUs, and home healthcare markets across 95+ countries.
- Ownership category
- akta.pro rank
NeoLight industry classification
Industry- Product category
- Neonatal Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Maternal & Neonatal Remote Monitoring Platforms (HLACAFAC)
Keywords
Where NeoLight is headquartered
LocationHeadquarters
- HQ city
- Scottsdale
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
NeoLight business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Hardware Sales: NeoLight generates revenue through the sale of capital medical equipment including Skylife Neonatal Phototherapy System, Phoenix ICON ophthalmic imaging systems, nëo CFM brain monitoring devices, and P.A.L. non-nutritive sucking devices. Products are sold to hospitals, clinics, and healthcare providers for neonatal care.
- Phoenix CONNECT Software Platform: Cloud-based telemedicine platform for ophthalmic screening is offered as part of the product ecosystem, potentially generating recurring revenue through software subscriptions and services.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels8 records
NeoLight product offering
Product offeringCore offering
NeoLight designs, manufactures, and sells a portfolio of proprietary neonatal medical devices for hospitals and NICUs, organized across ocular screening (Phoenix ICON retinal imaging systems and Phoenix CONNECT telemedicine platform), jaundice care (Skylife phototherapy), brain monitoring (nëo CFM aEEG), non-nutritive sucking therapy (P.A.L.), and neonatal transport (NEOPOD, BABYPOD series, SCANPOD, BP37). The company sells capital equipment through direct sales in the US/Canada and via international distribution partners across 95+ countries, supplemented by GPO contracts and recurring software subscriptions.
Product overview
NeoLight is a medical device company offering a portfolio of empathy-driven neonatal care technologies organized across five product categories: (1) Ocular Screening via the Phoenix ICON platform family (Phoenix ICON desktop retinal imaging, Phoenix ICON GO portable imaging, and Phoenix CONNECT telemedicine platform); (2) Jaundice Care through the Skylife Neonatal Phototherapy System with best-in-class spectral power; (3) Brain Monitoring via the nëo CFM aEEG system; (4) Non-Nutritive Sucking through P.A.L. technology; and (5) Neonatal Transport including NEOPOD, BABYPOD series, SCANPOD, and BP37 thermal accessories. The company operates a platform-plus-products architecture, with Phoenix CONNECT serving as a cloud-based telemedicine hub connecting the various imaging and screening products across hospital networks.
Differentiator
Problem solved
Functional benefit
Products and services
- Phoenix ICON Retinal imaging system with patented Direct Illumination technology delivering superior high-resolution, high-contrast imaging on both light and dark retinas; sold direct in US/Canada and via distribution partners in 95+ countries for neonatal and pediatric ophthalmic screening.
- Phoenix ICON GO Lightweight, portable retinal imaging system capable of supporting large remote networks and inter-hospital subspecialties; FDA 510(k) cleared with expanded fluorescein angiography capabilities for neonatal and pediatric use.
- Phoenix CONNECT Cloud-based telemedicine communication platform for retinal imaging programs that connects nursing, ophthalmology, and neonatology teams to enable timely expert screening of babies in any NICU.
- Skylife Neonatal Phototherapy System Neonatal Phototherapy System with best-in-class spectral power and 3D Light Array providing 40% body surface coverage with effective, uniform light; FDA cleared for hospital and home use to treat hyperbilirubinemia.
- nëo CFM Brain Monitoring System Advanced brain monitoring system with aEEG (amplitude-integrated electroencephalography) for accelerated decision-making during neonatal care; exclusive USA partnership with ANT Neuro.
- P.A.L. (Pacifier Activated Lullaby) Therapeutic system that encourages and reinforces effective non-nutritive sucking of premature infants through positive audio feedback using parents' voices to promote progression of oral feeding.
- NEOPOD Safe, secure newborn baby transport system for neonatal and pediatric transport.
- BABYPOD 2 Infant transport device designed for safe neonatal transport with thermal regulation features.
- BABYPOD 20 Next-generation infant transport device with design advances for improved neonatal transport safety and functionality.
- SCANPOD Specialized transport pod designed for MRI, CT, or X-Ray imaging of infants.
- BP37 Thermal Support Kit Infant temperature maintenance kit providing thermal support accessory for Babypod transport systems.
- P.A.L. Music Service Service that empowers neonatal care with the sound of parents' voices, extending the P.A.L. therapeutic platform.
Quantifiable outcome
- 40% body surface coverage with Skylife 3D Light Array
- +4 more outcomes
Companies that use NeoLight
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
NeoLight technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
NeoLight partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered minor and core.
- Advanced Healthcare TechnologyminorStrategic partnership for continued expansion of the neonatal ecosystem, announced January 2026.
- Premier, Inc.coreKIINDO breakthrough technology agreement providing Premier members access to NeoLight's Skylife systems. Premier is the nation's largest member-driven healthcare performance improvement company.
- ANT NeurocoreExclusive USA partnership for the nëo CFM brain monitoring system. ANT Neuro provides EEG/aEEG technology expertise while NeoLight distributes and commercializes the system in the US market.
- Capstone Health AlliancecoreGPO contract with Capstone Health Alliance for Skylife Neonatal Phototherapy System, providing access to member hospitals.
- Florida State UniversitycorePartnership with Florida State University's National Institute for Infant and Child Medical Music Therapy to extend P.A.L. technology application. FSU provides research and clinical expertise in music therapy for premature infants while NeoLight provides the technological platform.
- InterVIEW Medical SystemsminorAgreement to acquire InterVIEW Medical Systems, a globally recognized provider of ROP education and examination content.
- Vizient, Inc.coreInnovative Technology contract awarded to NeoLight for Skylife Neonatal Phototherapy System. Vizient represents academic medical centers, pediatric facilities, community hospitals, and integrated health delivery networks representing more than $130 billion in annual purchasing volume.
- Phoenix Technology Group LLCcoreNeoLight acquired Phoenix Technology Group LLC, a provider of advanced ophthalmic imaging devices including Phoenix ICON, Phoenix ICON GO, and Phoenix CONNECT telemedicine platform. This acquisition expanded NeoLight's product portfolio to include ocular imaging and expanded global reach through PTG's distribution network in 95+ countries.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
NeoLight competitors and assessment
Company assessmentDirect peers
- Natus Medical: Natus Medical is a direct competitor in neonatal care devices, offering phototherapy (neoBLUE), brain monitoring (Olympic CFM), and hearing screening products that overlap directly with NeoLight's Skylife and nëo CFM lines, sold to the same NICU customer base.
- Drägerwerk: Dräger offers the Bililux phototherapy lamp, neonatal incubators, and transport systems that compete with NeoLight's Skylife phototherapy and BABYPOD/NEOPOD infant transport products in the same hospital NICU market.
- Masimo: Masimo competes in neonatal patient monitoring and brain monitoring technologies, overlapping with NeoLight's nëo CFM aEEG brain monitoring product line for neonatal care decision-making.
- Nidek: Nidek's RetCam retinal imaging system is the most established competitor to NeoLight's Phoenix ICON and ICON GO for pediatric and neonatal ROP screening, serving the same ophthalmology and neonatology hospital customers.
Broad incumbents
- GE Healthcare: GE Healthcare is a broad incumbent offering BiliBlanket phototherapy, Giraffe warmers, and other neonatal care equipment that compete with NeoLight's products as part of a much wider hospital portfolio, with substantially greater resources and global reach.
- Philips Healthcare: Philips is a broad incumbent in patient monitoring and neonatal care (including BiliTx phototherapy), competing with NeoLight across multiple categories as part of a large integrated healthcare portfolio.
- CooperSurgical: CooperSurgical serves women's and neonatal health markets with products spanning fertility, obstetrics, and newborn care, and overlaps with NeoLight's neonatal medical device portfolio as part of a broader women's health platform.
- Medtronic: Medtronic is a broad incumbent medical device company whose patient monitoring and respiratory products overlap with NeoLight's brain monitoring and neonatal respiratory-support adjacencies in hospital ICU settings.
Emerging players
- International Biomedical: International Biomedical manufactures neonatal transport incubators and infant care equipment that compete with NeoLight's BABYPOD, NEOPOD, and SCANPOD transport product line in the same hospital transport market.
- Clarity Medical Systems: Clarity Medical Systems offers pediatric retinal imaging systems for ROP screening that overlap with NeoLight's Phoenix ICON retinal imaging platform, targeting the same NICU and ophthalmology customers.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
NeoLight social profiles
Digital presenceNeoLight financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeoLight leadership team
Management profileNumber of profiles
Profiles17 records
NeoLight subsidiaries and ownership
Company hierarchySubsidiaries1 record
NeoLight funding detail
Funding detailFunding overview
Funding rounds8 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeoLight M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeoLight
What does NeoLight do?
NeoLight designs, manufactures, and sells a portfolio of proprietary neonatal medical devices for hospitals and NICUs, organized across ocular screening (Phoenix ICON retinal imaging systems and Phoenix CONNECT telemedicine platform), jaundice care (Skylife phototherapy), brain monitoring (nëo CFM aEEG), non-nutritive sucking therapy (P.A.L.), and neonatal transport (NEOPOD, BABYPOD series, SCANPOD, BP37). The company sells capital equipment through direct sales in the US/Canada and via international distribution partners across 95+ countries, supplemented by GPO contracts and recurring software subscriptions.
Is NeoLight a public or private company?
NeoLight is a private company. It is classified as venture growth investor backed.
When was NeoLight founded?
NeoLight was founded in 2014. It employs 11 to 50 people.
Where is NeoLight based?
NeoLight is headquartered in Scottsdale, United States, in the North America region.
How does NeoLight make money?
Two revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are phoenix CONNECT Software Platform.
Who are NeoLight's main competitors?
Direct peers on record are Natus Medical, Drägerwerk, Masimo and Nidek. Broad incumbents are GE Healthcare, Philips Healthcare, CooperSurgical and Medtronic. Emerging players are International Biomedical and Clarity Medical Systems.
Does NeoLight have an API?
No public API is recorded for NeoLight.
What industry is NeoLight in?
NeoLight's product category is Neonatal Medical Devices. Its primary akta.pro industry code is HLACAFAC, Maternal & Neonatal Remote Monitoring Platforms. Its NAICS code is 339113 and its SIC code is 3841.